Integrated Screening for Down's Syndrome Based on Tests Performed during the First and Second Trimesters, New England Journal of Medicine, vol.341, issue.7, pp.461-467, 1999. ,
DOI : 10.1056/NEJM199908123410701
Increased fetal nuchal translucency at 11???14???weeks, Prenatal Diagnosis, vol.106, issue.4, pp.308-315, 2002. ,
DOI : 10.1002/pd.308
Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region, BMJ, vol.325, issue.7354, p.15, 2002. ,
DOI : 10.1136/bmj.325.7354.15
Prenatal diagnosis in France, Eur J Hum Genet, vol.5, issue.1, pp.26-31, 1997. ,
Current french practices for prenatal diagnosis of trisomy 21: a population-based study in Paris, 1992-97, Prenatal Diagnosis, vol.297, issue.12, pp.1113-1118, 1999. ,
DOI : 10.1002/(SICI)1097-0223(199912)19:12<1113::AID-PD715>3.0.CO;2-5
Prenatal screening for trisomy 21 with maternal serum markers: information for decision-making in pregnant women, J Gynecol Obstet Biol Reprod (Paris), vol.29, issue.5, pp.492-500, 2000. ,
Recent trends in the prevalence of Down syndrome in north-eastern France, Ann Genet, vol.37, issue.4, pp.179-183, 1994. ,
What's the Relative Risk? A Method to Directly Estimate Risk Ratios in Cohort Studies of Common Outcomes, Annals of Epidemiology, vol.12, issue.7, pp.452-454, 2002. ,
DOI : 10.1016/S1047-2797(01)00278-2
Down syndrome fetal loss rate in early pregnancy, Prenatal Diagnosis, vol.14, issue.12, pp.1177-1179, 1999. ,
DOI : 10.1002/(SICI)1097-0223(199912)19:12<1177::AID-PD714>3.0.CO;2-N
Delayed childbearing, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.75, issue.1, pp.71-73, 1997. ,
DOI : 10.1016/S0301-2115(97)00190-5
Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening, BJOG: An International Journal of Obstetrics and Gynaecology, vol.21, issue.7, pp.18-21, 2003. ,
DOI : 10.1002/(SICI)1097-0223(199912)19:12<1175::AID-PD706>3.0.CO;2-K
pour la coordination nationale des enquêtes nationales périnatales. Trends in main indicators of perinatal health in France between 1995 and 1998. Results from the National Perinatal Surveys, J Gynecol Obstet Biol Reprod (Paris), vol.30, issue.16, pp.552-564, 2001. ,
Mothers??? knowledge of screening for trisomy 21 in 1999: a survey in Paris maternity units, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.104, issue.1, pp.14-20, 2002. ,
DOI : 10.1016/S0301-2115(01)00559-0
Births: final data for, Natl Vital Stat Rep, vol.50, issue.5, pp.1-101, 2000. ,
Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for Screening, New England Journal of Medicine, vol.330, issue.16, pp.1114-1122, 1994. ,
DOI : 10.1056/NEJM199404213301603
Efficacy of screening for fetal Down syndrome in the United States from, Obstet Gynecol, vol.96, issue.206, pp.979-985, 1974. ,
Effects of maternal age and education on the pattern of prenatal testing: Implications for the use of antenatal screening as a solution to the growing number of amniocenteses, American Journal of Obstetrics and Gynecology, vol.189, issue.5, pp.1336-1342, 2003. ,
DOI : 10.1067/S0002-9378(03)00643-4
Attributions for disability: The influence of genetic screening, Social Science & Medicine, vol.40, issue.8, pp.1127-1132, 1995. ,
DOI : 10.1016/0277-9536(94)00180-2
The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia, BJOG: An International Journal of Obstetrics and Gynaecology, vol.327, issue.12, pp.1453-1459, 2000. ,
DOI : 10.1016/0140-6736(92)93293-V